Business Context and Reporting Period
This Form 6-K filing is submitted by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in request metadata) for the month of September 2017. The filing incorporates by reference a press release dated September 7, 2017, titled "Notice of interim results."
Key Financial Metrics
The provided filing text serves as a cover sheet and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this document.
Material Changes
The filing text does not provide details regarding material changes versus prior comparable periods. It only indicates that interim results were announced via the attached press release.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the cover sheet text. These details are contained within the attached Exhibit 99.1 (Press Release), which is not included in the input content.
Investor Verification Checklist
- Verify the full text of the "Notice of interim results" press release (Exhibit 99.1) to obtain actual financial figures.
- Confirm the discrepancy between the request metadata ("Biodexa Pharmaceuticals Plc") and the filing registrant ("Midatech Pharma PLC").
- Review the interim results for specific updates on clinical trials or product development, as this is a pharmaceutical company.
- Check for any liquidity warnings or capital raise announcements in the full press release.